Frontlight ResearchEarly access
Taking people in United StatesNo phase
Watching for signs a pituitary tumor may come back
Observes adults with pituitary tumors to look for signs of regrowth and ongoing activity.
Key facts
- Who runs it
- Cedars-Sinai Medical Center
- Where
- Los Angeles, United StatesSee the site
- Trial code
- Registry title
- Pituitary Tumor Surveillance: Pathogenic Correlation
- Status
- Recruiting
- People taking part
- 1,250 people, planned
- Started
- Jan 1997
- Expected to end
- Dec 2050
- Type of study
- Observational
- Record updated
- 23 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a confirmed pituitary tumor or other pituitary disease of any type. It looks at signs that the tumor may come back or stay active.
- Age
- 18 Years and older
- Sex
- All sexes
- Disease stage
- Confirmed pituitary disease, including pituitary growths (mass lesions) of all types
Main reasons for not taking part
- People who do not have confirmed pituitary disease
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- patients with confirmed pituitary disease
Who cannot take part
- patients who do not have confirmed pituitary disease
Where in United States
- Cedars-Sinai Medical Center, Pituitary CenterLos Angeles, United StatesContact: Daniel GomezTaking people
About the trial
What the trial wants to find out
The purpose of this study is to observe predictors of pituitary tumor recurrence and markers of persistent disease activity in patients harboring pituitary mass lesions of all types.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Pituitary Tumor Surveillance: Pathogenetic Correlation
- Plain-language title
- Watching for signs a pituitary tumor may come backGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 23 March 2026